AOCC2024

07:00-08:00 (UTC+8) | Breakfast with the experts III | Drugs targeting the interleukin pathway: the present and future

Chair：

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	07:00-08:00	Breakfast with the experts III	Drugs targeting the interleukin pathway: the present and future	Fernando Magro	Faculty of Medicine of the University of Porto, Portugal

08:00-10:15 (UTC+8) | Clinical Forum II | Balance the benefits and risks for combination therapy

Chair：

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	08:00-08:25	Plenary Lecture	Combination therapy in children with IBD	Chuen-Bin Jiang	MacKay Children's Hospital, Taipei
2	08:25-08:50	Plenary Lecture	Application scenarios and prospectives of combination therapy of small molecule drugs and biological agents	Zhihua Ran	Zhou Pu Hospital, Shanghai University of Medicine & Health Sciences, Shanghai
3	08:50-09:15	Plenary Lecture	What we still have: combination therapy beside bio-bio or bio-SMD?	Jakob Begun	Mater Research Institute - The University of Queensland, Australia
4	09:15-09:25	Best Abstract VII	Altered CD4+T cell reactivity against yeasts in ASCA positive patients with Crohn's disease	Petra Bacher	Kiel University
5	09:25-09:35	Best Abstract Vlll	Trace element deficiency in lBD patients-a cross-sectional study	Gechong Ruan
6	09:45-10:15	Coffee Break & Poster Viewing

10:15-11:30 (UTC+8) | Asian Forum II | Stricturing Crohn's disease: perspectives on diagnosis, monitoring and management

Chair：

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	10:15-10:40	Plenary Lecture	Recent advances in cross-sectional imaging for assessing stricturing Crohn’s disease	Ren Mao	The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou
2	10:40-11:05	Plenary Lecture	Novel endoscopic management for stricturing Crohn’s disease	Bo Shen	New York-Presbyterian Hospital/Columbia University Irving Medical Center, USA
3	11:05-11:30	Plenary Lecture	Novel biologics, small molecules or mesenchymal stem cell therapy as therapeutic choices for stricturing Crohn’s disease	Eun Mi Song	Ewha Womans University College of Medicine, Seoul

11:30-13:00 (UTC+8) | Luncheon Symposium III | From biologics towards oral medication

Chair：

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	11:30-11:50	Plenary Lecture	The advantageous position of Chinese patent drugs in treatment of UC	Huahong Wang	Peking University First Hospital, Beijing
2	11:50-12:10	Plenary Lecture	Infliximab biosimilar therapy as a clinical treatment strategy for inflammatory bowel disease	Jun Shen	Renji Hospital,Shanghai Jiao Tong University, Shanghai
3	12:10-12:30	Plenary Lecture	Intestinal targeted biologic agent as the foundation for combination therapy with small molecule drugs: the prospectives	Xiuli Zuo	Qilu Hospital, Shandong University, Jinan
4	12:30-12:50	Plenary Lecture	Treatment strategies for luminal inflammatory CD: What's the difference	Jie Liang	Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi’an

13:00-14:20 (UTC+8) | Next Target of IBD in Asia

Chair：

Panel discussion：

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	13:00-13:20	Plenary Lecture	Next Target of IBD in Asia – update Asian guidelines with the development of pharmacology	Byong Duk Ye	University of Ulsan College of Medicine, Seoul
2	13:20-13:40	Plenary Lecture	Next Target of IBD in Asia – factors improving the quality of care	Msakazu Nagahori	Tokyo Medical and Dental University, Tokyo
3	13:40-14:00	Plenary Lecture	Next Target of IBD in Asia – establishing a pharmacoeconomic system	Zhanju Liu	Shanghai Tenth People's Hospital, Tongji University, Shanghai
4	14:00-14:20	Comment	Panel discussion Byong Duk Ye University of Ulsan College of Medicine, Seoul Kaichun Wu Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi’an Zhanju Liu Shanghai Tenth People's Hospital, Tongji University, Shanghai Taku Kobayashi Kitasato University Kitasato Institute Hospital, Tokyo

14:20-14:25 (UTC+8) | Hibi Award

Chair：

14:25-14:30 (UTC+8) | Prize-awarding Ceremony

Chair：

14:30-14:35 (UTC+8) | Closing Remarks

NO.	Beijing Time (UTC+8)	Type	Presentation Topic	Speaker	Affiliation / Organization
1	14:30-14:35	Closing Remarks	Zhanju Liu Shanghai Tenth People's Hospital, Tongji University, Shanghai Kaichun Wu Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi’an Minhu Chen The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou

2024-06-16 (Sunday)